ABAXIS INC Uncategorized Contracts & Agreements
21 Contracts & Agreements
- Third Amendment to the Exclusive Agreement between Abaxis, Inc. and Abbott Point of Care Inc. dated as of July 11, 2017 (Filed With SEC on August 9, 2017)
- Second Amendment to the Exclusive Agreement between Abaxis, Inc. and Abbott Point of Care Inc. dated as of March 7, 2017 and effective as of April 19, 2017 (Filed With SEC on August 9, 2017)
- Transition/Separation Agreement between Abaxis, Inc. and Vladimir E. Ostoich, Ph.D., dated August 15, 2014 (Filed With SEC on August 21, 2014)
- Amendment to Exclusive Agreement between Abaxis, Inc. and Abbott Point of Care Inc., dated September 30, 2013 (Filed With SEC on November 12, 2013)
- Exclusive Agreement, dated October 26, 2012, by and between Abbott Point of Care Inc. and the Company (Filed With SEC on February 11, 2013)
- Master Agreement, dated as of January 26, 2011, among the National Institute for Strategic Technology Acquisition and Commercialization, the Kansas State University Research... (Filed With SEC on June 13, 2011)
- Condensed Consolidated Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- Condensed Consolidated Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)
- Three Months Ended (Filed With SEC on February 9, 2009)
- Abaxis, Inc. (Filed With SEC on November 3, 2008)
- Distributor Agreement by and between the Veterinary Division of Henry Schein and Abaxis, Inc., dated April 5, 2004 (Filed With SEC on August 9, 2005)
- Our Industry: In-vitro Diagnostic Testing (Filed With SEC on July 1, 2002)
- Our Industry: In-vitro Diagnostic Testing (Filed With SEC on July 1, 2002)
- Amendment, dated April 4, 2013, to the Master Agreement by and among the Kansas State University Institute for Commercialization (f/k/a the National Institute for Strategic... (Filed With SEC on August 9, 2013)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo Xpress. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 14, 2010)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo Xpress. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 14, 2010)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo Xpress. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 14, 2010)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo Xpress. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 14, 2010)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo xpress. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 12, 2009)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo xpresstm. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 13, 2008)
- Medical Market: We currently market the blood analysis system in the medical market under the name Piccolo xpresstm. Through October 2006, we marketed the blood analysis system in... (Filed With SEC on June 13, 2008)
